Raycaster / evalsBack to AI Agents for FDA and Pharma Promotional Compliance

APEX-Agents · Investment Banking

World228_SM_Task08

0/1Fail

APEX-Agents task World228_SM_Task08 in AI Agents for FDA and Pharma Promotional Compliance. Compare dual-harness agent runs across models — rubric criteria, scores, and public traces.

AI Agents for FDA and Pharma Promotional ComplianceInvestment Banking World 228Dual harnessGrader: rubric
task_bfd79e55d1104d3e92486de9b3c4de12
Investment Banking World 228
message_in_console
4 models · dual config

Task prompt

What the agent was asked to do

From Becton Dickinson's FY2025 Annual Report assume the FDA finds that one violation regarding the Alaris SE infusion pumps, and decides the company is in violation, and enforces the consent decree on Alaris SE infusion pumps from November 29, 2024, to November 28, 2025, inclusive. Compute the average dollar burden of the penalty on BDX average shareholder. Output the result in USD as a reply to me here, rounded to 4 decimal places. Assume a 30-day month and a 360-day year.

Published trajectories

Agent runs on this task

Curated dual-harness runs (parsed + original sandbox). Best scored run per model.

ModelHarnessScoreResultLinks
GPT-5.5showcasedual0/1Fail
Gemini 3.1 Produal1/1Pass
GPT-5.4 minidual0/1Fail
GPT-5.4 nanodual1/1Pass

Grading rubric

Criteria and grader verdict (showcase run)

  1. States the average dollar burden of the penalty on BDX average shareholder stake is $542.2231

    Fail

    Evidence: <TEXT_RESPONSE> states “$0.0188” and explains “Dividing by FY2025 basic average shares outstanding ... gives $0.0188 per share.” Assessment: The criterion requires stating the average dollar burden on the BDX average shareholder stake is “$542.2231.” The response gives a different result ($0.0188), so it fails.